Photo=Motionelements South Korea’s aggressive decarbonization drive is accelerating the retreat of diesel-powered vehicles, with new diesel registrations falling below 100,000 units for the first time last year, according to industry data. The sharp decline highlights how government-led climate policy, tighter emissions standards and strong incentives for cleaner vehicles are reshaping one of Asia’s most advanced auto markets. Data from the

Photo=Hyundai Motor Group Hyundai Motor Group Chairman Chung Euisun made a series of high-profile visits to major technology companies at CES 2026, underscoring the South Korean automaker’s push to deepen partnerships in artificial intelligence and robotics as competition intensifies in next-generation mobility. On the opening day of the technology trade show, Mr. Chung toured booths operated by Doosan Group, Qualcomm,

(Photo=HYBE/MrBeast) MrBeast, the most-followed creator on YouTube, was unexpectedly drawn into a dispute far outside his usual realm after fans of the South Korean pop group NewJeans inundated his social media accounts with appeals to intervene in a contract conflict. The moment gained traction after a U.S. entertainment outlet reported that MrBeast’s TikTok comments were being flooded with messages urging

(Photo=Office of the President of the Republic of Korea) President Lee Jae-myung of South Korea and President Xi Jinping agreed this week to begin easing long-frozen bilateral ties by expanding cultural exchanges, a limited but politically safer step after years of strain driven by security disputes. Meeting in Beijing, the two leaders endorsed a gradual approach focused on areas considered

(Photo=Lotte) Lotte Holdings, the Japan-based holding company for South Korea’s Lotte Group, whose businesses span food, retail and chemicals, has made a strategic investment in a California biotechnology startup, underscoring how U.S.-based life sciences platforms are drawing capital from global industrial groups seeking early access to advanced research technologies. The investment was led by Lotte Holdings’ healthcare and biopharmaceutical corporate